EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Expression of Human Thrombomodulin Prevents Early Thrombocytopenia and Thrombotic Microangiopathy in Pig‐to‐Nonhuman Primate Orthotopic Liver Xenotransplantation

Zhongqiang Zhang, Ting Li iD, Qiang Li, Bin Xie, Xinger Zhao, Jianbin Wang, Yaxun Huang, Jing Luo, Shali Wen, Yinchun Zhou, Yong Deng, Yanfang Lu und 6 weitere

Xenotransplantation · 2026-03 · 33 (2)

DOI: 10.1111/xen.70120 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Xenotransplantation, online erschienen am 23.03.2026. Verfasst von Zhongqiang Zhang und 17 weiteren Autor:innen. Beteiligte Einrichtung: Department of Liver Transplantation, The Second Xiangya Hospital of Central South University, Changsha, Hunan, China. Hauptthemen laut MEDLINE: Transplantation, Heterologous, Thrombomodulin, Liver Transplantation, Thrombotic Microangiopathies. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 38 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Excellent Youth Foundation of Hunan Provincial Natural Science Foundation, Scientific Research Project of Hunan Provincial Health Commission, Key R&D Program of Hunan Province.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Severe thrombocytopenia and coagulation dysregulation remain major barriers to survival in pig‐to‐primate liver xenotransplantation models.

Methods

Porcine livers with five genetic modifications (GTKO, CMAHKO, β4GalNT2KO, hCD55, and hTBM) were orthotopically transplanted into four Tibetan macaques under two conventional immunosuppressive protocols. Longitudinal monitoring included graft and multi‐organ function, hematology, coagulation, and immune responses. Histopathological and immunohistochemical analyses were performed to characterize graft and recipient pathology.

Results

High expression of human thrombomodulin (hTBM) in donor livers effectively prevented early rapid and severe thrombocytopenia, with three of four recipients maintaining platelets >100 × 10 9 /L. Thrombotic microangiopathy (TMA) was absent in grafts and recipient organs despite transient hypercoagulability. No spontaneous bleeding occurred in three of four cases. However, porcine livers failed to synthesize functional coagulation factor II, protein C, and protein S, contributing to progressive coagulopathy. While early graft function and coagulation remained stable for four posttransplant days, late dysfunction ensued, characterized by impaired coagulation factor synthesis and progressive graft failure. Antibody‐mediated rejection, accompanied by IgM/IgG/C4b deposition, anti‐TKO antibody increase, and pvWF upregulation, triggered injury that was amplified by innate and T cell–mediated responses.

Conclusions

GTKO/CMAHKO/β4GalNT2KO/hCD55/hTBM donor liver transplantation was associated with an absence of early severe thrombocytopenia, transfusion requirement, and TMA, but long‐term survival was limited by immune‐mediated rejection and cross‐species incompatibilities in coagulation factor synthesis. Optimizing (i) donor genetic modifications and (ii) immunosuppressive therapy, with (iii) replacement of targeted coagulation factors will be crucial for achieving durable survival in pig liver xenotransplantation.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Transplantation, HeterologousThrombomodulinLiver TransplantationThrombotic MicroangiopathiesThrombocytopeniaAnimalsHumansSwineHeterograftsGraft SurvivalGraft RejectionMacacaLiver

Stichwörter der Autor:innen

Tibetan macaqueliverpigrejectionthrombocytopeniathrombotic microangiopathyxenotransplantation

Substanzen

ThrombomodulinTHBD protein, human

Autor:innen und Institutionen

  • Department of Liver Transplantation, The Second Xiangya Hospital of Central South University, Changsha, Hunan, China.
  • Department of Anesthesiology, The Second Xiangya Hospital of Central South University, Changsha, Hunan, China.
  • Operation Room, The Second Xiangya Hospital of Central South University, Changsha, Hunan, China.
  • Xenotransplantation and Regeneration Key Laboratory of Sichuan Province, Chengdu ClonOrgan Biotechnology Co. Ltd, Chengdu, China.
  • Center For Transplantation Sciences, Department of Surgery, Massachusetts General Hospital/Harvard Medical School, Boston, Massachusetts, USA.

ORCID-Profile: Ting Li, Jiequn Li, David K C Cooper, Dengke Pan

Förderung

  • Excellent Youth Foundation of Hunan Provincial Natural Science Foundation
  • Scientific Research Project of Hunan Provincial Health Commission
  • Key R&D Program of Hunan Province
  • Joint Fund of the National Natural Science Foundation
  • National Key R&D Program of China
  • National Key Research and Development Program of China

Zitieren

APA

Zhang, Z., Li, T., Li, Q., Xie, B., Zhao, X., Wang, J., Huang, Y., Luo, J., Wen, S., Zhou, Y., Deng, Y., Lu, Y., Jiang, Y., Li, J., Cooper, D. K. C., Pan, D., Si, Z., & Qi, H. (2026). Expression of Human Thrombomodulin Prevents Early Thrombocytopenia and Thrombotic Microangiopathy in Pig‐to‐Nonhuman Primate Orthotopic Liver Xenotransplantation. Xenotransplantation, 33(2). https://doi.org/10.1111/xen.70120

Vancouver

Zhang Z, Li T, Li Q, Xie B, Zhao X, Wang J, et al. Expression of Human Thrombomodulin Prevents Early Thrombocytopenia and Thrombotic Microangiopathy in Pig‐to‐Nonhuman Primate Orthotopic Liver Xenotransplantation. Xenotransplantation. 2026;33(2). doi:10.1111/xen.70120

BibTeX
@article{Zhang2026,
  author = {Zhang, Zhongqiang and Li, Ting and Li, Qiang and Xie, Bin and Zhao, Xinger and Wang, Jianbin and Huang, Yaxun and Luo, Jing and Wen, Shali and Zhou, Yinchun and Deng, Yong and Lu, Yanfang and Jiang, Yanyan and Li, Jiequn and Cooper, David K C and Pan, Dengke and Si, Zhongzhou and Qi, Haizhi},
  title = {Expression of Human Thrombomodulin Prevents Early Thrombocytopenia and Thrombotic Microangiopathy in Pig‐to‐Nonhuman Primate Orthotopic Liver Xenotransplantation},
  journal = {Xenotransplantation},
  year = {2026},
  volume = {33},
  number = {2},
  doi = {10.1111/xen.70120}
}
Kostenlos starten →